These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 349597)

  • 41. Monitoring of serum haloperidol.
    Lawson GM
    Mayo Clin Proc; 1994 Feb; 69(2):189-90. PubMed ID: 8309272
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of volume of distribution on plasma levels of total radioactivity.
    Cressman WA; Renzi NL; Bartholomay AC
    J Pharm Sci; 1972 Jul; 61(7):1170-1. PubMed ID: 5044823
    [No Abstract]   [Full Text] [Related]  

  • 43. Haloperidol.
    Inglis W
    Med J Aust; 1971 Dec; 2(26):1344. PubMed ID: 5128419
    [No Abstract]   [Full Text] [Related]  

  • 44. Double-blind trials.
    Newcombe RG
    Br J Psychiatry; 1990 Feb; 156():282. PubMed ID: 2180531
    [No Abstract]   [Full Text] [Related]  

  • 45. Increasing antipsychotic dose for non response in schizophrenia.
    Samara MT; Klupp E; Helfer B; Rothe PH; Schneider-Thoma J; Leucht S
    Cochrane Database Syst Rev; 2018 May; 5(5):CD011883. PubMed ID: 29750432
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of acute and transient psychotic disorders with low and high doses of oral haloperidol.
    Khanna A; Lal N; Dalal PK; Khalid A; Trivedi JK
    Indian J Psychiatry; 1997 Apr; 39(2):136-42. PubMed ID: 21584060
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intramuscular preparations of antipsychotics: uses and relevance in clinical practice.
    Altamura AC; Sassella F; Santini A; Montresor C; Fumagalli S; Mundo E
    Drugs; 2003; 63(5):493-512. PubMed ID: 12600227
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Choosing the right dose of antipsychotics in schizophrenia: lessons from neuroimaging studies.
    Tauscher J; Kapur S
    CNS Drugs; 2001; 15(9):671-8. PubMed ID: 11580306
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The relationship between serum concentration and therapeutic effect of haloperidol in patients with acute schizophrenia.
    Ulrich S; Wurthmann C; Brosz M; Meyer FP
    Clin Pharmacokinet; 1998 Mar; 34(3):227-63. PubMed ID: 9533984
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiemetic effect of haloperidol in the dog as related to plasma level and dose.
    Niemegeers CJ; Heykants JJ; Janssen PA
    Psychopharmacology (Berl); 1981; 75(3):240-4. PubMed ID: 6798613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma haloperidol levels and therapeutic response in acute mania and schizophrenia.
    Balant-Gorgia AE; Eisele R; Balant L; Garrone G
    Eur Arch Psychiatry Neurol Sci; 1984; 234(1):1-4. PubMed ID: 6489392
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic advantages of monitoring plasma concentrations of perphenazine in clinical practice.
    Hansen LB; Larsen NE
    Psychopharmacology (Berl); 1985; 87(1):16-9. PubMed ID: 3933033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of haloperidol.
    Froemming JS; Lam YW; Jann MW; Davis CM
    Clin Pharmacokinet; 1989 Dec; 17(6):396-423. PubMed ID: 2689040
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blood levels of haloperidol and clinical outcome in schizophrenia.
    Doddi S; Rifkin A; Karajgi B; Cooper T; Borenstein M
    J Clin Psychopharmacol; 1994 Jun; 14(3):187-95. PubMed ID: 8027415
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comparison of the therapeutic effects between haloperidol and insulin coma in schizophrenia and optimal blood levels of haloperidol].
    Shu L
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1987 Feb; 20(1):43-8. PubMed ID: 3304870
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of varying haloperidol plasma levels on negative symptoms in schizophrenia and schizoaffective disorder.
    Volavka J; Cooper TB; Czobor P; Meisner M
    Psychopharmacol Bull; 1996; 32(1):75-9. PubMed ID: 8927679
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Review of haloperidol blood level and clinical response: looking through the window.
    Volavka J; Cooper TB
    J Clin Psychopharmacol; 1987 Feb; 7(1):25-30. PubMed ID: 3546403
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Haloperidol dose, plasma levels, and clinical response: a double-blind study [proceedings].
    Ericksen SE; Hurt SW; Chang S
    Psychopharmacol Bull; 1978 Apr; 14(2):15-6. PubMed ID: 349597
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.